Corrigendum to 'FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic': [Journal of Thrombosis and Haemostasis Volume 22, Issue 4, April 2024, Pages 990-1000]